The Patent Finder

Stable Therapeutic Formulations

Alza Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 60/754,948, filed Dec 28, 2005. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,573,717Stable Therapeutic Formulations
In force
 · High confidence
Alza CorporationIn force
High confidence
US 8,632,801Stable Therapeutic Formulations
In force
 · Medium confidence
Alza CorporationIn force
Medium confidence
US 11,179,324Stable Therapeutic Formulations
In force
 · High confidence
Alza CorporationIn force
High confidence
Application 17/502,701Stable Therapeutic Formulations
Abandoned
Abandoned Feb 6, 2026
Alza CorporationAbandonedAbandoned Feb 6, 2026
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Alza Corporation.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited